• Tetanus Toxoid is indicated for active immunization against tetanus, a potentially life-threatening bacterial infection characterized by muscle stiffness and spasms. It is used to prevent tetanus infection in individuals who are at risk of exposure to the tetanus bacteria, such as those with contaminated wounds or as part of routine immunization schedules.
• Tetanus toxoid is also indicated for immunization against diptheria.

Tetanus

Diphtheria

• The dosage and administration of Tetanus Toxoid may vary depending on the specific vaccine formulation and the age of the individual. It is typically administered as an intramuscular injection.
• For primary immunization, a series of three doses is generally recommended, with the second and third doses given at specific intervals after the initial dose.
• Booster doses are recommended to maintain immunity and are typically administered every 10 years.

Adverse reactions to Tetanus Toxoid are generally mild and transient. Common side effects may include:

• Local reactions at the injection site, such as pain, redness, or swelling
• Mild fever
• Headache
• Fatigue or malaise
• Muscle aches

Pain at injection site

Fever

Headache

Fatigue

• Tetanus Toxoid should not be administered to individuals with a history of severe allergic reactions (anaphylaxis) to a previous dose of tetanus toxoid or any component of the vaccine.
• The healthcare provider should be informed of any history of neurological disorders or seizures before administering the vaccine.
• Tetanus Toxoid may be contraindicated or require special consideration in individuals with certain medical conditions or immunosuppressed individuals. Consult the specific prescribing information for detailed precautions.